Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

Frontiers of Medicine >> 2013, Volume 7, Issue 1 doi: 10.1007/s11684-013-0254-6

FGF23 associated bone diseases

Institute of Metabolism and Endocrinology, the Second Xiangya Hospital, Central South University, Changsha 410011, China

Available online: 2013-03-05

Next Previous

Abstract

Recently, fibroblast growth factor 23 (FGF23) has sparked widespread interest because of its potential role in regulating phosphate and vitamin D metabolism. In this review, we summarized the FGF superfamily, the mechanism of FGF23 on phosphate and vitamin D metabolism, and the FGF23 related bone disease.

Related Research